Thymomas and Thymic Carcinomas, Version 2.2025

  • Gregory J. Riely
  • , Douglas E. Wood
  • , Billy W. Loo
  • , Dara L. Aisner
  • , Wallace Akerley
  • , Jessica R. Bauman
  • , Ankit Bharat
  • , Joe Y. Chang
  • , Lucian R. Chirieac
  • , Malcolm DeCamp
  • , Aakash Desai
  • , Thomas J. Dilling
  • , Jonathan Dowell
  • , Gregory A. Durm
  • , Scott Gettinger
  • , Travis E. Grotz
  • , Matthew A. Gubens
  • , Aditya Juloori
  • , Rudy P. Lackner
  • , Michael Lanuti
  • Jules Lin, Christine M. Lovly, Fabien Maldonado, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Jonathan Riess, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina Gregory, Lisa Hang

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Thymomas and thymic carcinomas are rare mediastinal tumors that originate in the thymus. Patients with thymoma may experience symptoms associated with autoimmune paraneoplastic diseases (such as myasthenia gravis), which typically do not occur in patients with thymic carcinoma. The NCCN Guidelines for Thymomas and Thymic Carcinomas provide guidance for the diagnosis, treatment, and surveillance of patients with thymoma and thymic carcinoma. Involvement of a multidisciplinary team with experience treating thymomas and thymic carcinomas is highly recommended.

Original languageEnglish
Pages (from-to)255-269
Number of pages15
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume23
Issue number6
DOIs
StatePublished - Jun 2025

Fingerprint

Dive into the research topics of 'Thymomas and Thymic Carcinomas, Version 2.2025'. Together they form a unique fingerprint.

Cite this